Tagged with “Xeloda”
ArchivesSwitching from 5FU to Xeloda Can Cause Significant Side Effects
An immediate switch from 5-FU treatment to Xeloda® (capecitabine) for stage III colon cancer caused so much toxicity that a trial designed to test patient preferences for treatment had to be stopped.
Patients in the Patient Preference in Adjuvant Therapy (PACT) trial who switched after 6 weeks from weekly 5-FU with leucovorin to oral capecitabine experienced excessive side effects. The trial was designed to determine which approach to treatment patients liked best. Continue reading…
Posted by Kate Murphy on July 23rd, 2008
Posted in: Research & Treatment News | No Comments »
Tags: 5-FU, side effects, Xeloda
